Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study

被引：1

作者：

Bouabdallah, Krimo ^{[1
]}

Aubrais, Raphaelle ^{[1
]}

Chartier, Loic ^{[2
]}

Herbaux, Charles ^{[3
]}

Banos, Anne ^{[4
]}

Brice, Pauline ^{[5
]}

Ochmann, Marlene ^{[6
]}

Sibon, David ^{[7
,8
,9
]}

De Colella, Jean Marc Schiano ^{[10
]}

Cluzeau, Thomas ^{[11
]}

Laribi, Kamel ^{[12
]}

Le Calloch, Ronan ^{[13
]}

Bellal, Mathieu ^{[14
]}

Daguindau, Nicolas ^{[15
]}

Amorim, Sandy ^{[16
]}

Agbetiafa, Kossi ^{[17
]}

Chauchet, Adrien ^{[18
]}

Hammami, Marwa ^{[19
]}

Durot, Eric ^{[20
]}

Bonnet, Christophe ^{[21
]}

Robles, Margot ^{[22
]}

Fouillet, Ludovic ^{[23
]}

Bijou, Fontanet ^{[24
]}

Tournilhac, Olivier ^{[25
]}

Gaulard, Philippe ^{[26
]}

Parrens, Marie ^{[27
]}

Milpied, Noel-Jean ^{[28
]}

Damaj, Gandhi Laurent ^{[29
]}

机构：

[1] Bordeaux Univ Hosp, Serv Hematol Clin & Therapie Cellulaire, F-33000 Bordeaux, France

[2] Ctr Hosp Lyon Sud, LYSARC, Pierre Benite, France

[3] Montpellier Univ Hosp, Hematol Dept, Montpellier, France

[4] CH Cote Basque, Hematol Dept, Bayonne, France

[5] Univ Paris, Hop St Louis, AP HP, Hemato Oncol, Paris, France

[6] Hosp Orleans, Hematol Dept, Orleans, France

[7] INSERM, UMR 1163, Paris, France

[8] CNRS, INSERM, URL 8254, Paris, France

[9] Hop Necker Enfants Malad, AP HP, Serv Hematol, Paris, France

[10] Canc Inst, Inst Paoli Calmettes, Marseille, France

[11] CHU Nice, Dept Clin Hematol, Nice, France

[12] CH Le Mans, Dept Hematol, Le Mans, France

[13] Gen Hosp, Quimper, France

[14] Univ Hosp, Caen, France

[15] CH Annecy Genevois, Hematol Dept, Annecy, France

[16] Hosp Lille, Lille, France

[17] Hop Rene Huguenin, Inst Curie, St Cloud, France

[18] Besancon Univ Hosp, Hematol Dept, Besancon, France

[19] Univ Hosp, Versailles, France

[20] Serv Hematol, Reims, France

[21] Univ Hopsital, Angleur, Belgium

[22] Univ Hosp, Dumbea, France

[23] Canc Inst, St Etienne, France

[24] Canc Inst, Bordeaux, France

[25] Univ Clermont Auvergne, CHU, Serv Hematol Clin & Therapie Cellulaire, EA7453,CHELTER,CIC501, Clermont Ferrand, France

[26] Paris Est Creteil UPEC Univ Fac, Henri Mondor Hosp, AP HP, Dept Pathol,INSERM,UMR S 955, Creteil, France

[27] Univ Bordeaux Hosp, Pessac, France

[28] Hop Haut Leveque Pessac, Pessac, France

[29] CHU Caen Normandie, Caen, France

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-150953

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

620

引用

页数：4

共 50 条

[1] Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients
Ulu, Bahar Uncu
Dal, Mehmet Sinan
Hindilerden, Ipek Yonal
Akay, Olga Meltem
Mehtap, Ozgur
Buyukkurt, Nurhilal
Hindilerden, Fehmi
Gunes, Ahmet Kursad
Yigenoglu, Tugce Nur
Basci, Semih
Cakar, Merih Kizil
Acik, Didar Yanardag
Korkmaz, Serdal
Ulas, Turgay
Ozet, Gulsum
Ferhanoglu, Burhan
Nalcaci, Meliha
Altuntas, Fevzi
[J]. JOURNAL OF CHEMOTHERAPY, 2022, 34 (03) : 190 - 198
[2] Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study
Iannitto, Emilio
Romano, Alessandra
Scalzulli, Potito Rosario
Bonanno, Vincenza
Scalone, Renato
Chiarenza, Annalisa
Pirosa, Maria Cristina
Caruso, Anastasia Laura
Minoia, Carla
Mantuano, Saverio
De Santis, Gaetano
Salerno, Marilena
Crescimanno, Alessandra
Porretto, Ferdinando
Li Gioi, Felicina
Ricciuti, Giuseppina
Greco, Antonino
Pavone, Enzo
Guarini, Attilio
Tarantini, Giuseppe
Mannina, Donato
Consoli, Ugo
Cascavilla, Nicola
Di Raimondo, Francesco
Musso, Maurizio
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (06) : 581 - 587
[3] BRENTUXIMAB VEDOTIN PLUS BENDAMUSTINE AS A SALVAGE TREATMENT REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
LaCasce, A.
Bociek, G.
Sawas, A.
Caimi, P.
Agura, E.
Matous, J.
Ansell, S.
Crosswell, H.
Islas-Ohlmayer, M.
Behler, C.
Cheung, E.
Forero-Torres, A.
Vose, J.
O'Connor, O. A.
Josephson, N.
Advani, R.
[J]. HAEMATOLOGICA, 2016, 101 : 45 - 46
[4] Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
Aubrais, Raphaelle
Bouabdallah, Krimo
Chartier, Loic
Herbaux, Charles
Banos, Anne
Brice, Pauline
Sibon, David
Schiano, Jean Marc
Cluzeau, Thomas
Laribi, Kamel
Le Calloch, Ronan
Bellal, Mathieu
Delapierre, Baptiste
Daguindau, Nicolas
Amorim, Sandy
Agbetiafa, Kossi
Chauchet, Adrien
Besson, Caroline
Durot, Eric
Bonnet, Christophe
Fouillet, Ludovic
Bijou, Fontanet
Tournilhac, Olivier
Gaulard, Philippe
Parrens, Marie-Cecile
Damaj, Gandhi
[J]. BLOOD ADVANCES, 2023, 7 (19) : 5733 - 5742
[5] Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin
Zinzani, Pier Luigi
Derenzini, Enrico
Pellegrini, Cinzia
Celli, Monica
Broccoli, Alessandro
Argnani, Lisa
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (05) : 681 - 683
[6] Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma
Forlenza, Christopher J.
Gulati, Nitya
Mauguen, Audrey
Absalon, Michael J.
Castellino, Sharon M.
Franklin, Anna
Keller, Frank G.
Shukla, Neerav
[J]. BLOOD ADVANCES, 2021, 5 (24) : 5519 - 5524
[7] Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphoma
Van de Wyngaert, Zoe
Coppo, Paul
Cervera, Pascale
Fabiani, Bettina
Lemonnier, Marie-Paule
Corre, Elise
Marjanovic, Zora
Aoudjhane, Malek
Mohty, Mohamad
Dulery, Remy
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 467 - 472
[8] Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma
LaCasce, Ann S.
Bociek, Gregory
Sawas, Ahmed
Caimi, Paolo F.
Agura, Edward
Matous, Jeffrey
Ansell, Stephen
Crosswell, Howland
Islas-Ohlmayer, Miguel
Behler, Caroline
Cheung, Eric
Forero-Torres, Andres
Vose, Julie
O'Connor, Owen A.
Josephson, Neil
Advani, Ranjana
[J]. BLOOD, 2015, 126 (23)
[9] Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma
LaCasce, Ann S.
Bociek, R. Gregory
Sawas, Ahmed
Caimi, Paolo
Agura, Edward
Matous, Jeffrey
Ansell, Stephen M.
Crosswell, Howland E.
Islas-Ohlmayer, Miguel
Behler, Caroline
Cheung, Eric
Forero-Torres, Andres
Vose, Julie
O'Connor, Owen A.
Josephson, Neil
Wang, Yinghui
Advani, Ranjana
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (03) : E86 - E90
[10] Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma
Picardi, M.
Della Pepa, R.
Giordano, C.
Pugliese, N.
Mortaruolo, C.
Trastulli, F.
Rascato, M. G.
Cappuccio, I
Raimondo, M.
Memoli, M.
Monteverde, M.
Mascolo, M.
Pane, F.
[J]. BLOOD ADVANCES, 2019, 3 (09) : 1546 - 1552

← 1 2 3 4 5 →